Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Cancer Advances Inc.)"
Count: 15
Selected: 0
| NCT ID | Title |
|---|
| NCT03200821 | An Open Label Study to Evaluate G17DT Compared to Gemcitabine | ||
| NCT02521649 | Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer | ||
| NCT02518529 | Study to Assess Tolerability and Safety and Antibody Response to G17DT in Gastric Cancer Patients | ||
| NCT02518373 | Effect of G17DT in Patients With Stage II/III Colorectal Cancer | ||
| NCT02450032 | Study to Determine the Antibody Response to 500µg G17DT in Treatment of Patients With Gastric Cancer | ||
| NCT02233712 | Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer. | ||
| NCT02228785 | A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer | ||
| NCT02223078 | Two Center Study to Determine Effect of G17DT on Plasma Gastrin Levels in Patients With Colorectal Cancer. | ||
| NCT02181465 | Study to Assess Safety and Tolerability of G17DT in Patients With Colorectal Adenocarcinoma. | ||
| NCT02118077 | Sequential Trial of G17DT for the Treatment of Advanced Pancreatic Cancer | ||
| NCT02118064 | Phase II Study to Evaluate G17DT in Combination With Irinotecan in Patients With Colorectal Carcinoma | ||
| NCT02098291 | An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma | ||
| NCT02098239 | Single Centre Study to Determine the Antibody Response to G17DT in Patients With Advanced Pancreatic Cancer. | ||
| NCT00044031 | Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma | ||
| NCT00042510 | Safety and Efficacy of G17DT Immunogen in the Treatment of Gastric and Gastroesophageal Cancer |
